IRIDEX Corporation (IRIX)
USD 0.95
(-7.77%)
USD 0.95
(-7.77%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -7.44 Million USD | -5.74% |
| 2022 | -6.09 Million USD | -0.12% |
| 2021 | -6.73 Million USD | -14.43% |
| 2020 | -6.07 Million USD | 26.64% |
| 2019 | -8.28 Million USD | 30.26% |
| 2018 | -12.05 Million USD | 2.28% |
| 2017 | -12.17 Million USD | -466.37% |
| 2016 | -1.79 Million USD | -907.29% |
| 2015 | 810 Thousand USD | -88.87% |
| 2014 | 3 Million USD | -1.75% |
| 2013 | 2.65 Million USD | 258.61% |
| 2012 | 267 Thousand USD | -170.82% |
| 2011 | 2.84 Million USD | -29.23% |
| 2010 | 4.11 Million USD | 31.53% |
| 2009 | 4.21 Million USD | 140.04% |
| 2008 | -3.51 Million USD | 112.94% |
| 2007 | -17.79 Million USD | -91.97% |
| 2006 | -3.49 Million USD | -288.19% |
| 2005 | 2.24 Million USD | 394.49% |
| 2004 | -373 Thousand USD | -226.58% |
| 2003 | 655 Thousand USD | -16.04% |
| 2002 | 688 Thousand USD | 160.87% |
| 2001 | -1.13 Million USD | -132.16% |
| 2000 | 3.21 Million USD | 43.37% |
| 1999 | 2.29 Million USD | 27.75% |
| 1998 | 2.47 Million USD | -20.0% |
| 1997 | 3.02 Million USD | 400.0% |
| 1996 | 1.2 Million USD | -64.29% |
| 1995 | 1.5 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.89 Million USD | -36.06% |
| 2024 Q2 | -2.26 Million USD | 20.73% |
| 2023 Q3 | -1.68 Million USD | 41.67% |
| 2023 Q1 | -1.95 Million USD | -38.87% |
| 2023 FY | - USD | -5.74% |
| 2023 Q4 | -2.3 Million USD | -36.55% |
| 2023 Q2 | -2.89 Million USD | -47.8% |
| 2022 FY | - USD | -0.12% |
| 2022 Q4 | -1.41 Million USD | 10.98% |
| 2022 Q3 | -1.58 Million USD | 22.77% |
| 2022 Q1 | -2.15 Million USD | 9.97% |
| 2022 Q2 | -2.05 Million USD | 4.96% |
| 2021 Q4 | -2.39 Million USD | -23.88% |
| 2021 FY | - USD | -14.43% |
| 2021 Q1 | -1.84 Million USD | -513.67% |
| 2021 Q2 | -913 Thousand USD | 50.41% |
| 2021 Q3 | -1.93 Million USD | -111.94% |
| 2020 Q1 | -1.65 Million USD | -2.23% |
| 2020 Q2 | -2.78 Million USD | -68.42% |
| 2020 Q3 | -1.72 Million USD | 38.07% |
| 2020 Q4 | -300 Thousand USD | 82.6% |
| 2020 FY | - USD | 26.64% |
| 2019 Q2 | -2.46 Million USD | 18.71% |
| 2019 FY | - USD | 30.26% |
| 2019 Q4 | -1.61 Million USD | 12.74% |
| 2019 Q1 | -3.03 Million USD | -4.37% |
| 2019 Q3 | -1.85 Million USD | 24.92% |
| 2018 Q1 | -3.61 Million USD | 29.74% |
| 2018 Q2 | -3.28 Million USD | 9.26% |
| 2018 Q3 | -3.06 Million USD | 6.76% |
| 2018 Q4 | -2.9 Million USD | 4.93% |
| 2018 FY | - USD | 2.28% |
| 2017 Q1 | -1.85 Million USD | -122.25% |
| 2017 Q2 | -2.74 Million USD | -47.52% |
| 2017 Q4 | -5.14 Million USD | -50.48% |
| 2017 Q3 | -3.42 Million USD | -24.81% |
| 2017 FY | - USD | -466.37% |
| 2016 Q1 | 294 Thousand USD | -39.88% |
| 2016 Q2 | -245 Thousand USD | -183.33% |
| 2016 FY | - USD | -907.29% |
| 2016 Q4 | -836 Thousand USD | 32.96% |
| 2016 Q3 | -1.24 Million USD | -408.98% |
| 2015 FY | - USD | -88.87% |
| 2015 Q2 | -747 Thousand USD | -285.36% |
| 2015 Q1 | 403 Thousand USD | -59.04% |
| 2015 Q4 | 489 Thousand USD | 241.96% |
| 2015 Q3 | 143 Thousand USD | 119.14% |
| 2014 FY | - USD | -1.75% |
| 2014 Q1 | 597 Thousand USD | 7.37% |
| 2014 Q2 | 400 Thousand USD | -33.0% |
| 2014 Q3 | 606 Thousand USD | 51.5% |
| 2014 Q4 | 984 Thousand USD | 62.38% |
| 2013 Q4 | 556 Thousand USD | -16.39% |
| 2013 Q3 | 665 Thousand USD | 29.13% |
| 2013 Q2 | 515 Thousand USD | -49.66% |
| 2013 Q1 | 1.02 Million USD | 235.41% |
| 2013 FY | - USD | 258.61% |
| 2012 FY | - USD | -170.82% |
| 2012 Q4 | 305 Thousand USD | 164.62% |
| 2012 Q3 | -472 Thousand USD | 57.17% |
| 2012 Q2 | -1.1 Million USD | -1047.92% |
| 2012 Q1 | -96 Thousand USD | -107.54% |
| 2011 Q4 | 1.27 Million USD | 105.48% |
| 2011 Q1 | 731 Thousand USD | -64.91% |
| 2011 Q2 | -281 Thousand USD | -138.44% |
| 2011 FY | - USD | -29.23% |
| 2011 Q3 | 620 Thousand USD | 320.64% |
| 2010 FY | - USD | 31.53% |
| 2010 Q4 | 2.08 Million USD | 105.22% |
| 2010 Q2 | -541 Thousand USD | -171.66% |
| 2010 Q3 | 1.01 Million USD | 287.62% |
| 2010 Q1 | 755 Thousand USD | -26.98% |
| 2009 FY | - USD | 140.04% |
| 2009 Q4 | 1.03 Million USD | -12.0% |
| 2009 Q3 | 1.17 Million USD | 721.69% |
| 2009 Q1 | 597 Thousand USD | -9.13% |
| 2009 Q2 | -189 Thousand USD | -131.66% |
| 2008 Q2 | -210 Thousand USD | -347.06% |
| 2008 Q4 | 657 Thousand USD | 26.83% |
| 2008 Q3 | 518 Thousand USD | 346.67% |
| 2008 FY | - USD | 112.94% |
| 2008 Q1 | 85 Thousand USD | 129.51% |
| 2007 Q1 | -3.99 Million USD | -121.78% |
| 2007 FY | - USD | -91.97% |
| 2007 Q4 | -288 Thousand USD | -229.73% |
| 2007 Q3 | 222 Thousand USD | 105.48% |
| 2007 Q2 | -4.04 Million USD | -1.43% |
| 2006 FY | - USD | -288.19% |
| 2006 Q2 | -415 Thousand USD | 28.94% |
| 2006 Q3 | -1.34 Million USD | -225.06% |
| 2006 Q1 | -584 Thousand USD | -172.37% |
| 2006 Q4 | -1.8 Million USD | -33.43% |
| 2005 Q1 | -45 Thousand USD | -111.81% |
| 2005 Q2 | 668 Thousand USD | 1584.44% |
| 2005 Q3 | 814 Thousand USD | 21.86% |
| 2005 Q4 | 807 Thousand USD | -0.86% |
| 2005 FY | - USD | 394.49% |
| 2004 FY | - USD | -226.58% |
| 2004 Q4 | 381 Thousand USD | 128.69% |
| 2004 Q3 | -1.32 Million USD | -754.19% |
| 2004 Q2 | 203 Thousand USD | 290.38% |
| 2004 Q1 | 52 Thousand USD | -90.53% |
| 2003 Q1 | 26 Thousand USD | -97.82% |
| 2003 Q3 | 379 Thousand USD | 226.76% |
| 2003 Q4 | 549 Thousand USD | 44.85% |
| 2003 Q2 | -299 Thousand USD | -1250.0% |
| 2003 FY | - USD | -16.04% |
| 2002 Q2 | -500 Thousand USD | -357.85% |
| 2002 Q1 | -121 Thousand USD | -128.61% |
| 2002 FY | - USD | 160.87% |
| 2002 Q4 | 1.09 Million USD | 395.44% |
| 2002 Q3 | 210 Thousand USD | 143.5% |
| 2001 Q4 | 123 Thousand USD | 380.68% |
| 2001 Q3 | 176 Thousand USD | 1357.14% |
| 2001 Q2 | 114 Thousand USD | 99.55% |
| 2001 Q1 | -1.54 Million USD | -397.88% |
| 2001 FY | - USD | -132.16% |
| 2000 FY | - USD | 43.37% |
| 2000 Q4 | 518 Thousand USD | -41.14% |
| 2000 Q3 | 880 Thousand USD | -21.01% |
| 2000 Q2 | 1.11 Million USD | -4.79% |
| 2000 Q1 | 1.17 Million USD | -5.8% |
| 1999 Q1 | 297 Thousand USD | -66.67% |
| 1999 FY | - USD | 27.75% |
| 1999 Q4 | 1.24 Million USD | 107.0% |
| 1999 Q3 | 600 Thousand USD | 0.0% |
| 1999 Q2 | 600 Thousand USD | 500.0% |
| 1998 FY | - USD | -20.0% |
| 1998 Q4 | 400 Thousand USD | 200.0% |
| 1998 Q3 | 100 Thousand USD | -83.33% |
| 1998 Q2 | 700 Thousand USD | -40.0% |
| 1998 Q1 | 1.1 Million USD | -23.08% |
| 1997 Q4 | 1.4 Million USD | 116.67% |
| 1997 FY | - USD | 400.0% |
| 1997 Q2 | 800 Thousand USD | 500.0% |
| 1997 Q1 | 300 Thousand USD | -75.0% |
| 1997 Q3 | 800 Thousand USD | 0.0% |
| 1996 FY | - USD | -64.29% |
| 1996 Q1 | 2.4 Million USD | 147.06% |
| 1996 Q2 | 300 Thousand USD | -95.83% |
| 1996 Q3 | -100 Thousand USD | -200.0% |
| 1996 Q4 | 600 Thousand USD | 500.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q3 | 2.1 Million USD | -4.55% |
| 1995 Q4 | -5.1 Million USD | -342.86% |
| 1995 Q1 | 2.1 Million USD | 0.0% |
| 1995 Q2 | 2.2 Million USD | 4.76% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 44.776% |
| Cerus Corporation | -26.53 Million USD | 71.932% |
| OrthoPediatrics Corp. | -8.38 Million USD | 11.132% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 29.029% |
| Talis Biomedical Corporation | -66.04 Million USD | 88.723% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 55.334% |
| Inogen, Inc. | -45.67 Million USD | 83.695% |
| Spectral AI, Inc. | -12.26 Million USD | 39.26% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 84.383% |
| CVRx, Inc. | -38.73 Million USD | 80.77% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -111.111% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 38.482% |
| Orthofix Medical Inc. | -86.98 Million USD | 91.438% |
| Venus Concept Inc. | -26.11 Million USD | 71.478% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 85.035% |
| Bioventus Inc. | -23.07 Million USD | 67.716% |
| BrainsWay Ltd. | -2.31 Million USD | -222.285% |
| Envoy Medical, Inc. | -18.23 Million USD | 59.162% |
| electroCore, Inc. | -17.76 Million USD | 58.063% |
| IceCure Medical Ltd | -15.25 Million USD | 51.17% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 85.029% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 55.813% |
| MaxCyte, Inc. | -44.12 Million USD | 83.122% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 36.645% |
| Nexalin Technology, Inc. | -5.69 Million USD | -30.849% |
| PAVmed Inc | -75.74 Million USD | 90.167% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 86.145% |
| RxSight, Inc. | -41.03 Million USD | 81.851% |
| Sight Sciences, Inc. | -49.41 Million USD | 84.928% |
| SI-BONE, Inc. | -34.44 Million USD | 78.378% |
| TELA Bio, Inc. | -40.63 Million USD | 81.67% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 87.224% |
| Treace Medical Concepts, Inc. | -39 Million USD | 80.906% |
| LivaNova PLC | 39.01 Million USD | 119.09% |
| 908 Devices Inc. | -34.02 Million USD | 78.11% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 93.265% |
| Nemaura Medical Inc. | -7.28 Million USD | -2.209% |
| NeuroPace, Inc. | -22.83 Million USD | 67.382% |
| LENSAR, Inc. | -8.71 Million USD | 14.528% |
| Apyx Medical Corporation | -18.11 Million USD | 58.878% |
| Cutera, Inc. | -136.56 Million USD | 94.546% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -120.355% |
| BioSig Technologies, Inc. | -28.15 Million USD | 73.543% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 396.025% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 64.515% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 101.942% |
| Axonics, Inc. | 7.77 Million USD | 195.794% |
| Outset Medical, Inc. | -153.78 Million USD | 95.157% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 92.407% |
| IRadimed Corporation | 20.8 Million USD | 135.807% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 7.616% |
| INVO Bioscience, Inc. | -6.88 Million USD | -8.255% |
| Telesis Bio, Inc. | -40.49 Million USD | 81.607% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 120.307% |
| Varex Imaging Corporation | 67.2 Million USD | 111.083% |
| Quipt Home Medical Corp. | 44.07 Million USD | 116.9% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 31.481% |
| Pulmonx Corporation | -55.09 Million USD | 86.481% |
| Dynatronics Corporation | -976 Thousand USD | -663.108% |
| Modular Medical, Inc. | -17.1 Million USD | 56.452% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 48.581% |
| Semler Scientific, Inc. | 23.58 Million USD | 131.574% |
| InMode Ltd. | 196.28 Million USD | 103.795% |
| Bruker Corporation | 599 Million USD | 101.243% |
| Cytosorbents Corporation | -28.81 Million USD | 74.149% |
| DexCom, Inc. | 916.7 Million USD | 100.812% |
| Align Technology, Inc. | 799.03 Million USD | 100.932% |
| Viveve Medical, Inc. | -20.61 Million USD | 63.874% |
| ZimVie Inc. | 91.07 Million USD | 108.178% |
| Movano Inc. | -29.12 Million USD | 74.427% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -68.966% |
| Nexalin Technology, Inc. | -5.69 Million USD | -30.849% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -111.111% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 96.174% |
| Profound Medical Corp. | -27.12 Million USD | 72.54% |
| Insulet Corporation | 323.6 Million USD | 102.302% |
| enVVeno Medical Corporation | -25.01 Million USD | 70.229% |
| Surmodics, Inc. | 1.18 Million USD | 726.936% |
| iCAD, Inc. | -6.56 Million USD | -13.45% |
| Nuwellis, Inc. | -16.35 Million USD | 54.463% |
| Biotricity, Inc. | -8.82 Million USD | 15.635% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 92.311% |
| Aethlon Medical, Inc. | -11.84 Million USD | 37.143% |
| InspireMD, Inc. | -20.91 Million USD | 64.382% |
| PAVmed Inc. | -75.74 Million USD | 90.167% |
| BIOLASE, Inc. | -15.13 Million USD | 50.803% |
| Beyond Air, Inc. | -59.03 Million USD | 87.383% |
| FONAR Corporation | 28.25 Million USD | 126.363% |
| AxoGen, Inc. | -13.32 Million USD | 44.118% |
| Vivani Medical, Inc. | -26.6 Million USD | 72.008% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 130.349% |
| Inari Medical, Inc. | 7.11 Million USD | 204.71% |
| UFP Technologies, Inc. | 72.74 Million USD | 110.239% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -119.978% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -20.988% |
| Tenon Medical, Inc. | -15.52 Million USD | 52.035% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 51.212% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 82.043% |
| AdaptHealth Corp. | -171.09 Million USD | 95.647% |
| Sintx Technologies, Inc. | -6.6 Million USD | -12.848% |
| NanoVibronix, Inc. | -3.43 Million USD | -116.827% |
| Quanterix Corporation | -38.08 Million USD | 80.445% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 31.481% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 24926.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 97.314% |
| TransMedics Group, Inc. | -7.6 Million USD | 2.039% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 65.78% |
| NeuroMetrix, Inc. | -7.09 Million USD | -4.963% |
| Hyperfine, Inc. | -47.06 Million USD | 84.174% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 87.226% |
| Biomerica, Inc. | -5.99 Million USD | -24.278% |
| Bone Biologics Corporation | 479.57 Thousand USD | 1653.051% |
| AVITA Medical, Inc. | -39.56 Million USD | 81.177% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 18.805% |
| Silk Road Medical, Inc | -45.08 Million USD | 83.478% |